Drugs / SI000413
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01525758 | Jan 2012 → Dec 2013 | osteoarthritis, knee | Dong-A Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SI000413 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01525758 ↗ |
| Route | Oral | “by orally administration” NCT01525758 ↗ |